CervoMed

CervoMed

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$2.13-$10.89
Market Cap
$40M
Shares Short
962,576

Financials

See more
Revenue (12 Mos)
$331,295
Revenue Growth (YoY)
-99.6%
Gross Profit (12 Mos)
-$21.5M
Diluted EPS
-$3.23

News

See more

Yahoo Finance • last month

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

Yahoo Finance • 2 months ago

CervoMed Completes Enrollment In Phase 2a Study Of Neflamapimod For Nfv.Primary Progressive Aphasia

Yahoo Finance • 2 months ago

CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia

Yahoo Finance • 2 months ago

CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026

About

CEO
Dr. John J. Alam M.D.
CFO
Mr. William Robert Elder J.D.
Address
20 Park Plaza, Boston, MA, United States, 02116
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
15